Intraepithelial cervical carcinoma and HIV: Prevalence, risk factors and prevention strategies;Carcinoma cervicale intraepiteliale ed HIV Prevalenza, fattori di rischio e strategie di prevenzione

Minerva Ginecologica

Volumn 55, Issue 1, 2003, Pages 51-55

  Soncini, E ^a,b   Condemi, V ^a  

^a Ostetriche Neonatol Univ Stud   (Italy)

^b NONE   (Italy)

Author keywords

Cervical intraepithelial neoplasia, diagnosis; Cervical intraepithelial neoplasia, epidemiology; Cervical intraepithelial neoplasia, pathology; Colposcopy; HIV Infections

Indexed keywords

ADULT; AGE; ARTICLE; CANCER SCREENING; CANCER STAGING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SEROLOGY; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADULT; BIOPSY; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; ITALY; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARITY; PREVALENCE; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 0037318639     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993;269:729-30.
2. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7.
3. Jan N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read 2000;10:659-68.
4. Heard I, Tassie J, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol 2000;96:403-9.
5. nd ed., vol. 1. Edinburg: Churchill Livingstone; 1992.p.309.
6. Wright TC Jr, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994;84:591-7.
7. Boccalon M, Tirelli U, Sopracordevole F, Vaccher E. Intra-epithelial and invasive cervical neoplasia during HIV infection. Eur J Cancer 1996;32A:2212-7.
8. Koss L. The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA 1989;261:737-43.
9. Spinillo A, Capuzzo E, Tenti P, De Santolo A, Piazzi G, Iasci A. Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women. Gynecol Oncol 1998;69:109-13.
10. CDC. 1998 Guideliness for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47:1-111.
11. Fink MJ, Fruchter RG, Maiman M, Kelly P, Sedlis A, Webber CA et al. The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol 1994;55:133-7.
12. Del Priore G, Maag T, Bhattacharya M, Garcia PM, Till M, Lurain JR. The value of cervical cytology in HIV-infected women. Gynecol Oncol 1995;56:395-8.
13. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.